"NIH's RECOVER Initiative: Advancing Long COVID Treatment Studies and Enrollment"
TL;DR Summary
The National Institutes of Health (NIH) has launched phase 2 clinical trials through its RECOVER Initiative to evaluate potential treatments for long COVID. The trials will test at least four treatments initially, with more expected in the coming months. The aim is to identify effective treatments for the most burdensome symptoms of long COVID. The trials will focus on viral persistence, cognitive dysfunction, sleep disturbances, autonomic nervous system problems, and exercise intolerance and fatigue. The NIH is committed to a coordinated and rigorous approach to finding relief for the millions of people living with long COVID.
- NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment National Institutes of Health (.gov)
- Brain fog and other long COVID symptoms are the focus of new small treatment studies The Associated Press
- Suffering from long COVID? Here's how a new NIH study could help ease symptoms USA TODAY
- Biden administration announces launch of HHS office focused on long Covid research CNN
- NIH announces long-covid treatment studies with hundreds of patients The Washington Post
Reading Insights
Total Reads
1
Unique Readers
10
Time Saved
7 min
vs 8 min read
Condensed
94%
1,555 → 96 words
Want the full story? Read the original article
Read on National Institutes of Health (.gov)